GT-919

N/A

Report date: 2025/08/12 20:00:05
NME

Base Information

Drug NameGT-919
Drug Alias NameGT-919
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionZinc finger protein Aiolos degradersDNA-binding protein Ikaros degraders
TargetsZinc finger protein AiolosDNA-binding protein Ikaros
Therapy Area/IndicationsPOEMS SyndromeHematologic NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsPOEMS SyndromeHematologic NeoplasmsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A